Back to Top Skip to main content

WRAIR begins Phase 1 clinical trial of Marburg vaccine

The WRAIR study evaluates the VRC-MARADC087-00-VP vaccine, developed by the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. (U.S. Army file photo) The WRAIR study evaluates the VRC-MARADC087-00-VP vaccine, developed by the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. (U.S. Army file photo)

Recommended Content:

Immunization Healthcare | Immunizations

SILVER SPRING, Md. — The Walter Reed Army Institute of Research (WRAIR) recently administered the first vaccine in a Phase 1 clinical trial to evaluate the safety and immunogenicity of a Marburg vaccine candidate in healthy adult volunteers.

The WRAIR study evaluates the VRC-MARADC087-00-VP vaccine, developed by the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). The recombinant chimpanzee adenovirus type 3-vectored Marburg virus vaccine candidate being tested is aimed at stimulating rapid but durable immunity. This vaccination strategy is considered optimal to protect both first-line health workers and general populations in areas where outbreaks occur.

“Given the recent deadly outbreak of Marburg virus in Uganda, there is a critical need to develop a safe and effective vaccine which has the potential to protect our soldiers and the public from this serious threat,” said Army Lt. Col. Melinda Hamer, Chief of the WRAIR Clinical Trials Center in Silver Spring, Maryland, where the trial is being conducted.

Forty healthy, adult volunteers will be enrolled and assigned into one of two groups to evaluate different vaccine dosages. Volunteers will be closely followed over the course of approximately one year after vaccination for safety and immune system response.

The Marburg virus is in the same family as Ebola and causes severe hemorrhagic fever in humans. Case fatality rates in Marburg outbreaks have ranged from 24% to 88%. The most recent outbreak occurred in Uganda in 2017.

WRAIR conducted the first Ebola vaccine clinical trial in Africa in 2009, testing an early vaccine candidate also developed by the VRC at NIAID. During the 2014 West Africa Ebola outbreak, WRAIR conceived of, and then initiated a Phase I clinical trial of the VSV-EBOV vaccine candidate over a period of just 11 weeks at its CTC. WRAIR has conducted six Ebola vaccine studies to date.

“This first-in-human trial of the NIH vaccine is part of an important inter-agency effort by the US government to anticipate and counter emerging infectious threats to the Americans, both military and civilian, at home and abroad,” added Dr. Kayvon Modjarrad, the Director of the Emerging Infectious Diseases Branch at WRAIR.

You also may be interested in...

Vaccines: A public health success story

Article
8/7/2019
Tech Sgt. Joseph Anthony, medical technician with the 911th Aeromedical Staging Squadron, administers a vaccination to a member of the U.S. Army Reserve’s 336 Engineering Company Command and Control, Chemical Radiological and Nuclear Response Enterprise Team at the Pittsburgh International Airport Air Reserve Station, Pennsylvania, April 11, 2019. Department of Defense-issued vaccinations are used to prevent a variety of diseases that military members may encounter in the course of their duties. (U.S. Air Force photo by Joshua J. Seybert)

Maintaining a medically ready force is just one of many reasons to vaccinate

Recommended Content:

Preventive Health | Immunizations | Immunization Healthcare | Vaccine-Preventable Diseases

CDC Yellow Book

Publication
7/19/2019

CDC Health Information for International Travel 2020

Recommended Content:

Immunization Healthcare

General Best Practice Guidelines for Immunization

Publication
7/9/2019

The Centers for Disease Control and Prevention (CDC) recommends routine vaccination to prevent 17 vaccine-preventable diseases that occur in infants, children, adolescents, or adults. This report provides information for clinicians and other health care providers about concerns that commonly arise when vaccinating persons of various ages.

Recommended Content:

Immunization Healthcare | Vaccine Recommendations | Continuous Quality Immunization Improvement Process (CQIIP) and Virtual Continuous Quality Immunization Improvement Process (VCQIIP)

Checklist: Best Practices for Vaccination Clinics Held at Satellite, Temporary, or Off-Site Locations

Publication
6/21/2019

A step-by-step guide to help clinic supervisors follow Centers for Disease Control and Prevention (CDC) and Department of Defense (DoD) guidelines while overseeing any nontraditional vaccination clinic setting.

Recommended Content:

Immunization Healthcare | Vaccine-Preventable Diseases | Vaccine Storage and Handling

Hospital honored for Hepatitis B vaccine birth dose rate

Article
6/10/2019
Navy Hospital Corpsman 3rd Class Tommy Baker checks on Navy Logistics Specialist Seaman Tabernesha Victrum and Romeo Taylor as they hold their newborn daughter at Naval Hospital Jacksonville’s Maternal Infant Unit. (U.S. Navy photo by Jacob Sippel)

NH Jacksonville is the newest entry into IAC’s Birth Dose Honor Roll

Recommended Content:

Military Hospitals and Clinics | Immunization Healthcare

Resolution of Payments to State Vaccine Programs

Congressional Testimony
4/17/2019

S. 3159, SAC Report for FY 2019, 115-290, Pg. 207

Recommended Content:

Immunization Healthcare

Measles vaccine protects against potentially serious illness

Article
4/4/2019
A Salvadoran nurse vaccinates a baby during a Task Force Northstar mission in El Salvador to provide medical care and other humanitarian and civic assistance. The mission involved U.S. military personnel working alongside their Brazilian, Canadian, Chilean, and Salvadoran counterparts. (U.S. Army Photo by Sgt. Kim Browne)

387 cases to date among civilian population

Recommended Content:

Immunization Healthcare | Vaccine-Preventable Diseases | Vaccine Recommendations | Children's Health

Medical helps prevent the flu amongst service members through teamwork

Article
2/15/2019
Members of DLA Troop Support Medical supply chain and DLA Distribution pose for a photo at an after action review for the Department of Defense’s Influenza Vaccination Program at Fort Detrick, Maryland Feb. 5, 2019. The Medical supply chain made approximately 3.4 million doses of the influenza vaccine available at military treatment facilities and U.S. Navy Fleet clinics around the world in support of the DOD’s Influenza Vaccination Program. (DoD photo by Alexander Quiñones)

The Medical supply chain made approximately 3.4 million doses of the influenza vaccine available

Recommended Content:

Immunization Healthcare | Immunizations | Combat Support

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2019

Report
2/8/2019

The 2019 child and adolescent immunization schedule summarizes the recommendations of the Advisory Committee on Immunization Practices (ACIP), including several changes from the 2018 immunization schedule.

Recommended Content:

Immunization Healthcare | Vaccine-Preventable Diseases | Vaccine Schedules

Vaccination is the best defense against the flu

Article
12/10/2018
Vaccination is the primary method for preventing influenza and its complications and getting an annual influenza vaccine is the best way to protect yourself and your family from the flu. (U.S. Army photo by Staff Sgt. Erica Knight)

Vaccination is needed every year because the Influenza viruses change

Recommended Content:

Health Readiness | Immunization Healthcare | Immunizations

Updated Framework for Development of Evidence-Based Recommendations by the Advisory Committee on Immunization Practices

Report
11/16/2018

In 2010, the Advisory Committee on Immunization Practices (ACIP) implemented the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach for developing evidence-based recommendations. Since its February 2018 meeting, ACIP has incorporated the use of Evidence to Decision or Evidence to Recommendation (EtR) frameworks into GRADE methodology.

Recommended Content:

Immunization Healthcare | Vaccine Recommendations

Global Routine Vaccination Coverage — 2017

Report
11/16/2018

Global coverage with vaccines to prevent diphtheria, tetanus, pertussis, polio, and measles has remained at 84%–85% since 2010. Prioritizing countries with the highest number of unvaccinated children to implement context-specific strategies has the potential to increase immunization coverage globally.

Recommended Content:

Immunization Healthcare | Measles-Mumps-Rubella | Polio | Tetanus-Diphtheria-Pertussis

Immunization Tool Kit 9th Edition

Publication
10/25/2018

A practical reference that facilitates and enhances the global delivery of quality immunization healthcare to Department of Defense (DoD) beneficiaries and employees. The Defense Health Agency Immunization Healthcare Branch (DHA-IHB) publishes the Immunization Tool Kit based on national recommendations, evidenced-based, peer-reviewed published medical literature, and clinical practice guidelines.

Recommended Content:

Immunization Healthcare

Vaccination Coverage for Selected Vaccines and Exemption Rates Among Children in Kindergarten — United States, 2017–18 School Year

Report
10/12/2018

Immunization programs conduct annual kindergarten vaccination assessments to monitor school-entry vaccination coverage for all state-required vaccines. Median vaccination coverage was 94.3% for 2 doses of measles, mumps, and rubella vaccine; 95.1% for the state-required number of doses of diphtheria and tetanus toxoids and acellular pertussis vaccine; and 93.8% for 2 doses of varicella vaccine.

Recommended Content:

Immunization Healthcare | Vaccine-Preventable Diseases | Vaccine Schedules

Vaccination Coverage Among Children Aged 19–35 Months — United States, 2017

Report
10/12/2018

The Advisory Committee on Immunization Practices recommends routine vaccination by age 24 months against 14 potentially serious illnesses. In 2017, coverage with most recommended vaccines among children aged 19–35 months remained stable and high but was lower in more rural areas and among uninsured or Medicaid-insured children.

Recommended Content:

Immunization Healthcare | Vaccine-Preventable Diseases | Vaccine Schedules
<< < 1 2 3 4 5 > >> 
Showing results 1 - 15 Page 1 of 5

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing; Download a PDF Reader or learn more about PDFs.